Poster presentation highlights promising results from Phase 1b/2 TENACITY-01 study of CTD402 in T-Cell and myeloid leukemias Findings underscore potential to address unmet needs in multiple ...
In his first extended interview since joining the company, AKQA Global CEO Baiju Shah explains why he is bullish on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results